Format
Sort by
Items per page

Send to

Choose Destination

Best matches for kidney AND kidney failure, chronic:

Age and treatment of kidney failure. Elliott MJ et al. Curr Opin Nephrol Hypertens. (2013)

Low estimated glomerular filtration rate and chronic kidney failure following liver transplant: a retrospective cohort study. Narciso RC et al. Int J Artif Organs. (2013)

Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. Humphreys BD et al. J Clin Invest. (2013)

Search results

Items: 1 to 20 of 98944

1.

Impact of achieved blood pressure on renal function decline and first stroke in hypertensive patients with chronic kidney disease.

Li Y, Liang M, Jiang C, Wang G, Li J, Zhang Y, Fan F, Sun N, Cui Y, He M, Tang G, Yin D, Cheng X, Wang B, Huo Y, Xu X, Hou FF, Xu X, Qin X.

Nephrol Dial Transplant. 2017 Sep 19. doi: 10.1093/ndt/gfx267. [Epub ahead of print]

PMID:
29036427
2.

Effects of fasting during the month of Ramadan on renal function in patients with autosomal dominant polycystic kidney disease
.

Ekinci I, Erkoc R, Gursu M, Dogan EE, Kilic E, Cebeci E, Ozturk S, Kazancioglu R.

Clin Nephrol. 2017 Oct 16. doi: 10.5414/CN109102. [Epub ahead of print]

PMID:
29035195
3.

Long-term treatment with chaethomellic acid A reduces glomerulosclerosis and arteriolosclerosis in a rat model of chronic kidney disease.

Nogueira A, Vala H, Vasconcelos-Nóbrega C, Faustino-Rocha AI, Pires CA, Colaço A, Oliveira PA, Pires MJ.

Biomed Pharmacother. 2017 Oct 12;96:489-496. doi: 10.1016/j.biopha.2017.09.137. [Epub ahead of print]

PMID:
29032332
4.

Salvia miltiorrhiza protects adenine-induced chronic renal failure by regulating the metabolic profiling and modulating the NADPH oxidase/ROS/ERK and TGF-β/Smad signaling pathways.

Cai H, Su S, Li Y, Zeng H, Zhu Z, Guo J, Zhu Y, Guo S, Yu L, Qian D, Tang Y, Duan J.

J Ethnopharmacol. 2017 Oct 11. pii: S0378-8741(17)31024-3. doi: 10.1016/j.jep.2017.09.021. [Epub ahead of print]

PMID:
29032117
5.

[Outcome of living kidney donors for transplantation].

Lanot A, Bouvier N, Chatelet V, Lecouf A, Tillou X, Ligny BH.

Nephrol Ther. 2017 Oct 11. pii: S1769-7255(17)30173-6. doi: 10.1016/j.nephro.2017.02.011. [Epub ahead of print] French.

PMID:
29031488
6.

Treatment of Disorders of Sodium Balance in Chronic Kidney Disease.

Ellison DH.

Adv Chronic Kidney Dis. 2017 Sep;24(5):332-341. doi: 10.1053/j.ackd.2017.07.003. Review.

PMID:
29031361
7.

Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension.

Kovesdy CP, Appel LJ, Grams ME, Gutekunst L, McCullough PA, Palmer BF, Pitt B, Sica DA, Townsend RR.

J Am Soc Hypertens. 2017 Oct 6. pii: S1933-1711(17)30337-6. doi: 10.1016/j.jash.2017.09.011. [Epub ahead of print]

PMID:
29030153
8.

Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension.

Kovesdy CP, Appel LJ, Grams ME, Gutekunst L, McCullough PA, Palmer BF, Pitt B, Sica DA, Townsend RR.

Am J Kidney Dis. 2017 Sep 29. pii: S0272-6386(17)30921-6. doi: 10.1053/j.ajkd.2017.09.003. [Epub ahead of print]

PMID:
29029808
9.

Clinical Heterogeneity and Phenotypic Expansion of NaPi-IIa-Associated Disease.

Demir K, Yildiz M, Bahat H, Goldman M, Hassan N, Tzur S, Ofir A, Magen D.

J Clin Endocrinol Metab. 2017 Sep 29. doi: 10.1210/jc.2017-01592. [Epub ahead of print]

PMID:
29029121
10.

Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.

Peters V, Zschocke J, Schmitt CP.

J Inherit Metab Dis. 2017 Oct 13. doi: 10.1007/s10545-017-0099-2. [Epub ahead of print] Review.

PMID:
29027595
11.

Preoperative management of arteriovenous fistula (AVF) for hemodialysis.

Alfano G, Fontana F, Iannaccone M, Noussan P, Cappelli G.

J Vasc Access. 2017 Oct 11:0. doi: 10.5301/jva.5000771. [Epub ahead of print]

PMID:
29027182
12.

Outcomes of acute kidney injury in a nephrology ward.

Fernandes AR, Viegas MSR, Soares EQ, Coelho SS, Valério P, Barreto JC, Vinhas JM.

Int Urol Nephrol. 2017 Oct 11. doi: 10.1007/s11255-017-1716-6. [Epub ahead of print]

PMID:
29027072
13.

Chromogranin A as a Biochemical Marker for Neuroendocrine Tumors: A Single Center Experience at Royal Hospital, Oman.

Al-Risi ES, Al-Essry FS, Mula-Abed WS.

Oman Med J. 2017 Sep;32(5):365-370. doi: 10.5001/omj.2017.71.

PMID:
29026467
14.

Disparity between Nephrologists' Opinions and Contemporary Practices for Community Follow-Up after AKI Hospitalization.

Karsanji DJ, Pannu N, Manns BJ, Hemmelgarn BR, Tan Z, Jindal K, Scott-Douglas N, James MT.

Clin J Am Soc Nephrol. 2017 Oct 12. pii: CJN.01450217. doi: 10.2215/CJN.01450217. [Epub ahead of print]

PMID:
29025786
15.

Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease.

Bolia R, Srivastava A, Yachha SK, Poddar U.

J Hepatol. 2017 Oct 9. pii: S0168-8278(17)32348-6. doi: 10.1016/j.jhep.2017.10.001. [Epub ahead of print]

PMID:
29024698
16.

Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances.

Bierzynska A, Saleem MA.

Pediatr Nephrol. 2017 Oct 11. doi: 10.1007/s00467-017-3793-2. [Epub ahead of print] Review.

PMID:
29022104
17.

Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis.

Bazoukis G, Letsas KP, Korantzopoulos P, Thomopoulos C, Vlachos K, Georgopoulos S, Karamichalakis N, Saplaouras A, Efremidis M, Sideris A.

J Arrhythm. 2017 Oct;33(5):417-423. doi: 10.1016/j.joa.2017.04.005. Epub 2017 May 1. Review.

18.

Sustained activation of guanylate cyclase-A with TDT, a natriuretic peptide derivative, exhibits cardiorenal protection in Dahl salt-sensitive hypertensive rats.

Oishi S, Suzuki N, Hasui Y, Homma T, Obana M, Nagayama T, Fujio Y.

J Pharmacol Exp Ther. 2017 Oct 11. pii: jpet.117.244459. doi: 10.1124/jpet.117.244459. [Epub ahead of print]

19.

Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease.

Samad Z, Sivak JA, Phelan M, Schulte PJ, Patel U, Velazquez EJ.

J Am Heart Assoc. 2017 Oct 11;6(10). pii: e006044. doi: 10.1161/JAHA.117.006044.

20.

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.

Gane E, Lawitz E, Pugatch D, Papatheodoridis G, Bräu N, Brown A, Pol S, Leroy V, Persico M, Moreno C, Colombo M, Yoshida EM, Nelson DR, Collins C, Lei Y, Kosloski M, Mensa FJ.

N Engl J Med. 2017 Oct 12;377(15):1448-1455. doi: 10.1056/NEJMoa1704053.

PMID:
29020583

Supplemental Content

Loading ...
Support Center